| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |